Dictionary of Pharmaceutical Medicine pdf free download

Dictionary of Pharmaceutical Medicine

Pharmaceutical medicine and terminology is expanding rapidly, combining a large number of disciplines and sciences. It is hard to keep path with the steadily increasing amount of information. Biologics and biosimilars are now making up a growing proportion of new market entrants; regenerative medicine and RNA biopharmaceuticals, both still in its infancy 20 years ago, impress in our days with a growing number of products streaming to the market. Cell- as well as gene-therapy is more and more important as an option for an individualized medicine and to treat rare or difficult-to-treat conditions.

Modern techniques not only allow to study the regulation of genomes, their expression, transcription processes, and deviations that penultimately cause directly or indirectly diseases but pave also the way for new treatments. Some biological regulators such as miRNAs and siRNAs, subjects of basic research until the end of the last century, are now recognized as a distinct class of biologicals with the potential of a completely new group of therapeutics. Accumulated evidence on genetics and epigenetics of the circadian system points to important implications of this network of genes that are intertwined in an intricate transcriptional/translational feedback loop, in disease. One day, this may allow optimizing interventions. Although chronotherapy is still at its beginning in the clinical practice, its potential role in pharmacotherapy, but also for dietary measures, is of growing importance.
Other new terms added or explanations that have been enlarged concern (product) quality and safety, verification of supply chains for prescription products, as well as typical “grey zones” to nonprescription medicines, cosmetics, and nutritional supplements.
This fourth edition of the dictionary aims to contribute for a better under- standing of the increasingly complex field of pharmaceutical medicine. The number of terms has increased from about 2000 to roughly 2700; the number of acronyms that are commonly used in pharmaceutical medicine has more than doubled to over 1600 abbreviations, many of them with multiple meanings. As with the previous editions, cross-references bring terms in relation to other areas. Some links to useful websites are now integrated in the text. Although more comfortable for users, this bears the risk that such links may have changed after having been reviewed. I apologize if this is the case.
I hope that this new edition will find the same interest as the previous versions, among researchers in and outside of the pharmaceutical industry, including investigators, regulatory and marketing departments, as well as of other groups interested in this fascinating, integrative science that contributes so much to human health.